RT Book, Section
A1 Friedman, Lawrence S.
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
SR Print(0)
ID 1175808488
T1 Chronic Viral Hepatitis
T2 Current Medical Diagnosis & Treatment 2021
YR 2021
FD 2021
PB McGraw-Hill Education
PP New York, NY
SN 9781260469868
LK accessmedicine.mhmedical.com/content.aspx?aid=1175808488
RD 2023/03/29
AB Key  Clinical  Updates  in  Chronic  Viral  HepatitisIn  2019,  the  American  Association  for  the  Study  of  Liver  Diseases  and  the  Infectious  Diseases  Society  of  America  recommended  two  preferred  regimens  for  hepatitis  C:  glecaprevir  and  pibrentasvir  for  8  weeks  for  genotypes  1-6,  and  sofosbuvir  and  velpatasvir  for  12  weeks  for  genotypes  1,  2,  4,  5,  or  6.